CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced the launch of a new program specifically geared towards using ...
Group testing algorithms are an emerging frontier in applied mathematics and computer science that focus on the efficient identification of defective items within large populations through pooled ...
Flow cytometry–triggered genomic testing and automation reduced turnaround times for AML diagnostics, enhancing personalized therapy and patient care. The initiative involved clinician education, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results